Quipt Home Medical Corp. (QIPT)
NASDAQ: QIPT · Real-Time Price · USD
2.420
-0.030 (-1.22%)
Nov 20, 2024, 4:00 PM EST - Market closed
Quipt Home Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Quipt Home Medical stock have an average target of 7.67, with a low estimate of 6.00 and a high estimate of 10. The average target predicts an increase of 216.94% from the current stock price of 2.42.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 21, 2024.
Analyst Ratings
The average analyst rating for QIPT stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +189.26% | Aug 21, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $8 → $6 | Strong Buy | Maintains | $8 → $6 | +147.93% | Aug 16, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | +271.90% | May 20, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | +230.58% | May 17, 2024 |
| Raymond James | Raymond James | Buy → Hold Downgrades $10 | Buy → Hold | Downgrades | $10 | +313.22% | Feb 16, 2024 |
Financial Forecast
Revenue This Year
263.61M
from 211.68M
Increased by 24.53%
Revenue Next Year
273.33M
from 263.61M
Increased by 3.69%
EPS This Year
-0.12
from -0.07
EPS Next Year
-0.01
from -0.12
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 272.8M | 288.4M | 298.0M |
| Avg | 263.6M | 273.3M | 286.1M |
| Low | 252.2M | 258.9M | 271.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 28.9% | 9.4% | 9.0% |
| Avg | 24.5% | 3.7% | 4.7% |
| Low | 19.1% | -1.8% | -0.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.08 | 0.14 | 0.11 | ||
| Avg | -0.12 | -0.01 | 0.07 | ||
| Low | -0.13 | -0.12 | 0.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.